Publications by authors named "Omer Emgin"
Article Synopsis
- Glycemic variability (GV) is a common issue in critically ill patients, and this study explored its impact on 28-day mortality through a multicenter analysis involving 578 patients across five ICUs in Turkey.
- The study tracked several glycemic parameters within the first 24 hours, finding significant differences in CV (coefficient of variation), SD (standard deviation), and MGD (maximal-minimal glucose difference) between survivors and non-survivors, with higher levels linked to increased mortality risk.
- Results indicated that CV is an independent risk factor for mortality, with a strong correlation with MGD, suggesting that monitoring these glycemic metrics could be critical for predicting patient outcomes in intensive care settings.
Objective: This study aimed to assess the effect of prone position on oxygenation and lung recruitability in patients with acute respiratory distress syndrome due to COVID-19 receiving invasive mechanical ventilation.
Methods: This prospective study was conducted in the intensive care unit between December 10, 2021, and February 10, 2022. We included 25 patients admitted to our intensive care unit with acute respiratory distress syndrome due to COVID-19 who had undergone prone position.
Convalescent plasma for COVID-19 in the intensive care unit.
Anaesthesiol Intensive Ther
February 2022
Introduction: We aimed to investigate the clinical features and mortality of critically ill patients treated with convalescent plasma for COVID-19 in the intensive care unit (ICU).
Material And Methods: We retrospectively collected clinical and laboratory data of COVID-19 patients treated in the ICU. The patients were divided into two groups: those who received convalescent plasma and those who did not.
Background: Hemophagocytic syndrome (HPS) ia s devastating hyperinflammatory syndrome. Heart failure (HF) with preserved ejection fraction (HFpEF) status is closely correlated with increased inflammation, both systemic and intramyocardial.
Objectives: This study sought to determine mortality predictors and reliable follow-up parameters in HPS that developed HFpEF during the clinical course.